首页> 美国政府科技报告 >Task 89-07: Evaluation of the In Vitro Efficacy of Candidate Pretreatment andTreatment (PT) Compounds Against Vesicants and Nerve Agents
【24h】

Task 89-07: Evaluation of the In Vitro Efficacy of Candidate Pretreatment andTreatment (PT) Compounds Against Vesicants and Nerve Agents

机译:任务89-07:评估候选预处理和治疗(pT)化合物对抗囊泡剂和神经毒剂的体外效力

获取原文

摘要

MREF Task 89-07 encompassed four vesicant assays and four nerve agent assays. Thefour vesicant assays evaluated the candidate P and T compound solubility limitations, direct cytotoxic effects, efficacy against HD-induced cellular nicotinamide adenine dinucleotide (NAD+) depletion, and efficacy against HD-induced cytotoxicity. Normal human epidermal cells (NHEKs) were used to evaluate candidate PT compound efficacy against HD-induced NAD+ depletion, and peripheral blood mononuclear leukocytes (PBMC) were used in direct cytotoxicity and HD-induced cytotoxicity assays. The four nerve agent assays assessed candidate PT compound direct inhibitory effects on acetylcholinesterase (AChE) activity,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号